In mice receiving the combination of 17-AAG and antigen-specific CD4+ T cells, tumor regrowth was significantly delayed, with only 2/6 mice reaching the experimental endpoints (Fig 8C, right bottom panel). The gene discussed is CD4; the disease is neoplasm.